Entry Detail



General Information

Database ID:exR0000124
RNA Name:ACAT1
RNA Type:mRNA
Chromosome:chr11
Starnd:+
Coordinate:
Start Site(bp):108116695End Site(bp):108147603
External Links:ENSG00000075239



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ATP2A2
chr12
110280756
110351093
+
MTRNR2L8
chr11
10507894
10509186
-
TRIP10
chr19
6737925
6751530
+
NPEPPS
chr17
47522942
47623276
+
DAPK1
chr9
87497228
87708634
+
PSMB5
chr14
23016543
23035230
-
CCDC102A
chr16
57512181
57536571
-
FZD3
chr8
28494205
28574267
+
NCAM1
chr11
112961247
113278436
+
PRDX4
chrX
23664262
23686397
+
PSMD10
chrX
108084207
108091549
-
PGK1
chrX
77910739
78129295
+
HSP90AB1
chr6
44246166
44253888
+
NPIPB2
chr16
11927259
11976643
-
TXNRD1
chr12
104215779
104350307
+
MRPL47
chr3
179588285
179604649
-
AC010422.3
chr19
12643831
12648397
-
GHITM
chr10
84139509
84153568
+
POU3F3
chr2
104853287
104858574
+
RPS4X
chrX
72255679
72277248
-
DAP3
chr1
155687960
155739010
+
EEF1A1
chr6
73515750
73523797
-
GLI2
chr2
120735623
120992653
+
IER3IP1
chr18
47152834
47176364
-
RPLP1
chr15
69452814
69456205
+
ACTG1
chr17
81509971
81523847
-
IGFBP2
chr2
216632828
216664436
+
NUP205
chr7
135557917
135648757
+
ACTB
chr7
5527148
5563784
-
TXNDC16
chr14
52430596
52552522
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
MIR155HG
chr21
25561909
25575168
+
POLR2J4
chr7
43940895
44019175
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.